Tag: Diabetes: Misc.
American Diabetes Association, June 20-23
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
Sustained reduction seen in body weight versus placebo for adults aged 18 to 75 with overweight or obesity, without diabetes
Increasing Proportion of U.S. Adults Unaware They Have Hypertension
No change seen in proportion of adults unaware they had diabetes or high cholesterol levels
GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
More than twofold increased risk seen for nAMD development in unadjusted and adjusted models
High Transepidermal Water Loss in Diabetic Foot Ulcer Tied to Recurrence
High TEWL at center of recently healed diabetic foot ulcer linked to increased odds of recurrence
Lamivudine Improves Visual Acuity in Center-Involved Diabetic Macular Edema
Best corrected visual acuity improved 9.8 letters with lamivudine after four weeks, decreased 1.8 letters with placebo
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes
Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality
